The largest multidisciplinary imaging and oncology conference in the UK
Breaking barriers in MRI
Today more than ever, access to healthcare should be a matter of course. But barriers still exist that limit the reach and quality of care. For MRI, those barriers may seem prohibitive, but often they are only imposed by conventions. In this session see how MAGNETOM Free.Max breaks barriers to expand the reach of MRI. Where patients have felt discomfort, the world's first 80 cm bore sets a new paradigm in patient comfort. Where infrastructure was an obstacle to MRI, MAGNETOM Free.Max slots into an existing helium-free infrastructure. Where access to MRI was not viable, MAGNETOM Free.Max makes access affordable. And where conventions have limited our thinking, MAGNETOM Free.Max breaks out of conventions to explore new clinical opportunities in MRI.
Artificial Intelligence in the prostate cancer pathway
With the acquisition of Varian Medical Systems, Siemens Healthineers is creating a unique, highly integrated portfolio of imaging, laboratory diagnostics, artificial intelligence and treatment for the global fight against cancer. Hear how as a combined company our AI portfolio can support you and your patients through the prostate cancer pathway.
myNeedle Companion for CT
Time and precision are critical in CT-guided intervention but even in routine in-plane percutaneous needle procedures, precise targeting can be cumbersome, with nothing to help the radiologist visualise critical anatomical structures. This session will provide an overview of how Siemens Healthineers’ new advances support interventional CT from routine to complex procedures. myNeedle Companion. Universal. Simple. Powerful. Available on SOMATOM X.ceed.
Community diagnostic hubs – Exploring the challenges of transforming care delivery
Siemens Healthineers has long been an advocate of community diagnostics, developing solutions to improve patient accessibility. We understand that every community diagnostic hub will be unique, influenced by integrated care systems and local patient pathway requirements. In this session we explore the challenges voiced to us by NHS stakeholders and discuss how, as a trusted partner, we can help to deliver your vision for community diagnostics in a sustainable and cost-effective way.